On February 4, we celebrate World Cancer Day – a day that unites people, communities and entire countries to raise awareness and take action.
Cancer is a global challenge. 10 million people die from cancer every year.
This year’s World Cancer Day‘s theme, “Close the Care Gap”, raises awareness of the equity gap that affects almost everyone, in high as well as low- and middle-income countries. However, the prospects of major advances in tackling cancer have never been greater, and international collaboration and funding are essential in realizing these opportunities.
Did you know that…?
- 10 million people die from cancer every year.
- At least one third of common cancers are preventable.
- Cancer is the second-leading cause of death worldwide.
ZEISS contributes to cancer research, diagnosis and therapy
ZEISS plays an important role in the fight against cancer. Both in labs, companies and at hospitals, ZEISS systems support cancer research, diagnostics and treatment:
Looking for One in Many Millions
Epic Sciences (USA) conduct analyses from a single blood draw and produce comprehensive cancer profiles, including information on circulating tumor cells (CTCs) .
Understanding Drug Resistant Cervical Cancer Cells
Dr. Pontsho Moela at the University of Pretoria (South Africa) uses widefield microscopy to understand the behavior of persister cells from cervical cancer cells in response to cisplatin and RBBP6 gene silencing.
What is World Cancer Day?
World Cancer Day is led by the UICC, the Union for International Cancer Control. World Cancer Day is one singular initiative with thousand members from across 172 countries under which the entire world can unite together in the fights against the global cancer epidemic.
Learn more:
Discover ZEISS solutions for cell biology and live-cell imaging here.
Find out more about World Cancer Day activities.
#advgb-infobox-1372ac39-3c32-45fd-9e61-11a94883614c, .advgb-infobox-1372ac39-3c32-45fd-9e61-11a94883614c {background-color: #f5f5f5;padding: 20px 20px 20px 20px;border: 0px solid #e8e8e8 ;border-radius: 0px;}#advgb-infobox-1372ac39-3c32-45fd-9e61-11a94883614c .advgb-infobox-icon-container, .advgb-infobox-1372ac39-3c32-45fd-9e61-11a94883614c .advgb-infobox-icon-container {background-color: #f5f5f5;padding: 0;margin: 0;border: 0px solid #e8e8e8 ;border-radius: 0px;}#advgb-infobox-1372ac39-3c32-45fd-9e61-11a94883614c .advgb-infobox-icon-container i, .advgb-infobox-1372ac39-3c32-45fd-9e61-11a94883614c .advgb-infobox-icon-container i {color: #333;font-size: 70px;display: block;}#advgb-infobox-1372ac39-3c32-45fd-9e61-11a94883614c .advgb-infobox-textcontent .advgb-infobox-title, .advgb-infobox-1372ac39-3c32-45fd-9e61-11a94883614c .advgb-infobox-textcontent .advgb-infobox-title {color: #333;padding: 0;margin: 5px 0 10px 0;white-space: pre-wrap;}#advgb-infobox-1372ac39-3c32-45fd-9e61-11a94883614c .advgb-infobox-textcontent .advgb-infobox-text, .advgb-infobox-1372ac39-3c32-45fd-9e61-11a94883614c .advgb-infobox-textcontent .advgb-infobox-text {color: #333;padding: 0;margin: 0;white-space: pre-wrap;}